New approaches to therapy of amyotrophic lateral sclerosis.
Miller
R G
RG
D000085:Acetates / Q000627:therapeutic use; D000588:Amines; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000628:therapy; D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D000077206:Gabapentin; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D051379:Mice; D019782:Riluzole / Q000627:therapeutic use*; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D019208:Brain-Derived Neurotrophic Factor; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists; D005680:gamma-Aminobutyric Acid; D007334:Insulin-Like Growth Factor I; D000077206:Gabapentin; D019782:Riluzole